Liabilities, Current of NRX Pharmaceuticals, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
NRX Pharmaceuticals, Inc. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • NRX Pharmaceuticals, Inc. Liabilities, Current for the quarter ending 30 Sep 2025 was $40,593,000, a 100% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

NRX Pharmaceuticals, Inc. Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $40,593,000 +$20,294,000 +100% 30 Sep 2025 10-Q 14 Nov 2025 2024 Q3
Q2 2025 $40,453,000 30 Jun 2025 10-Q 18 Aug 2025 2024 Q2
Q1 2025 $32,751,000 31 Mar 2025 10-Q 15 May 2025 2024 Q1
Q4 2024 $21,863,000 +$2,815,000 +15% 31 Dec 2024 10-Q 14 Nov 2025 2024 Q3
Q3 2024 $20,299,000 +$972,000 +5% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q4 2023 $19,048,000 +$3,463,000 +22% 31 Dec 2023 10-K 14 Mar 2025 2024 FY
Q3 2023 $19,327,000 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $22,617,000 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $22,064,000 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $15,585,000 +$3,662,000 +31% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q4 2021 $11,923,000 -$34,241,225 -74% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $36,769,262 +$36,390,064 +9597% 30 Sep 2021 10-Q/A 12 Aug 2022 2021 Q3
Q2 2021 $57,801,671 +$57,504,433 +19346% 30 Jun 2021 10-Q/A 12 Aug 2022 2021 Q2
Q4 2020 $46,164,225 +$45,541,784 +7317% 31 Dec 2020 10-Q/A 12 Aug 2022 2021 Q3
Q3 2020 $379,198 -$262,547 -41% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $297,238 -$223,913 -43% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $316,381 -$178,014 -36% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $622,441 +$55,031 +9.7% 31 Dec 2019 10-Q 16 Nov 2020 2020 Q3
Q3 2019 $641,745 +$266,170 +71% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $521,151 +$303,702 +140% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $494,395 +$429,276 +659% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $567,410 +$474,239 +509% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 $375,575 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 $217,449 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $65,119 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 $93,171 31 Dec 2017 10-K 15 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.